Salvatore Chillemi, MD
Nephrology · Marietta, GANPI 1285839431
Payments from drug & device makers
Across 964 payments — averaging $297.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$97K
- Mallinckrodt Hospital Products Inc.$55K
- Mallinckrodt Enterprises LLC$45K
- Amgen$28K
- Akebia Therapeutics Inc$17K
- Vifor Pharma, Inc.$15K
- plus $29K from 25 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 211 | $97,179 |
| Mallinckrodt Hospital Products Inc. | 97 | $55,230 |
| Mallinckrodt Enterprises LLC | 61 | $45,403 |
| Amgen(2 entities) | 162 | $28,361 |
| Akebia Therapeutics Inc | 51 | $17,120 |
| Vifor Pharma, Inc. | 64 | $14,615 |
| Ardelyx, Inc. | 26 | $13,873 |
| Bayer | 26 | $4,266 |
| Calliditas Therapeutics US Inc. | 30 | $3,675 |
| Aurinia Pharma U.S., Inc. | 8 | $2,993 |
| Travere Therapeutics, Inc. | 33 | $915 |
| Otsuka America Pharmaceutical, Inc. | 44 | $905 |
| Alnylam Pharmaceuticals Inc. | 16 | $417 |
| OPKO Pharmaceuticals, LLC | 39 | $350 |
| Fresenius USA Marketing, Inc. | 22 | $303 |
| ANI Pharmaceuticals, Inc. | 15 | $289 |
| Novartis | 11 | $272 |
| GSK | 11 | $208 |
| Sanofi | 7 | $151 |
| Baxter Healthcare | 2 | $104 |
| Daiichi Sankyo Inc. | 5 | $102 |
| Novo Nordisk | 4 | $86 |
| Ultragenyx Pharmaceutical Inc. | 4 | $65 |
| Boehringer Ingelheim | 3 | $56 |
| Lilly USA, LLC | 3 | $53 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $43 |
| Shield Therapeutics Inc | 2 | $42 |
| Apellis Pharmaceuticals, Inc. | 2 | $31 |
| Johnson & Johnson | 1 | $17 |
| Vantive US Healthcare LLC | 1 | $16 |
| Rhythm Pharmaceuticals, Inc. | 1 | $16 |
How this compares
$287,155 in reported general payments places this provider in the 95th percentile of 388 nephrology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nephrology in Marietta
- James TumlinLawrenceville$19.8M
- Chinedu NwekeAcworth$3.9M
- Vinayak RamanathLagrange$3.1M
- Harold HubertAugusta$2.8M
- Tamorie SmithColumbus$1.9M
- Barton BrezinaAugusta$1.5M
- Frederic Rahbari OskouiAtlanta$1.5M
- Rajeev ChauhanColumbus$1.1M
- Sagar PanseMacon$1.1M
- Laura MulloyAugusta$891K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.